Pill

Asmussen , et al. March 29, 2

Patent Grant D947358

U.S. patent number D947,358 [Application Number D/760,683] was granted by the patent office on 2022-03-29 for pill. This patent grant is currently assigned to Novo Nordisk A/S. The grantee listed for this patent is Novo Nordisk A/S. Invention is credited to Martin Asmussen, Mette Hog Gauno.


United States Patent D947,358
Asmussen ,   et al. March 29, 2022

Pill

Claims

CLAIM The ornamental design for a pill, as shown and described.
Inventors: Asmussen; Martin (Bagsv.ae butted.rd, DK), Gauno; Mette Hog (Bagsv.ae butted.rd, DK)
Applicant:
Name City State Country Type

Novo Nordisk A/S

Bagsv.ae butted.rd

N/A

DK
Assignee: Novo Nordisk A/S (N/A)
Appl. No.: D/760,683
Filed: December 3, 2020

Related U.S. Patent Documents

Application Number Filing Date Patent Number Issue Date
29684226 Mar 19, 2019 D906513

Current U.S. Class: D24/101
Current International Class: 2401
Field of Search: ;D24/100-104

References Cited [Referenced By]

U.S. Patent Documents
D403396 December 1998 Lundbom
D425614 May 2000 Chen
D430285 August 2000 Chen
D431076 September 2000 Chen
D434846 December 2000 Chen
6165513 December 2000 Dansereau
D459798 July 2002 Desesquelle
D475451 June 2003 Bell et al.
D535021 January 2007 Stawski et al.
D564086 March 2008 Nielsen
D636865 April 2011 Vepuri
D671636 November 2012 Nishino
D735315 July 2015 Bhat
D754841 April 2016 Waldman
D787042 May 2017 Parikh
D787043 May 2017 Parikh
D813372 March 2018 Parikh
D835257 December 2018 Parikh
D835258 December 2018 Parikh
D858741 September 2019 Parikh
D906513 December 2020 Asmussen
D907760 January 2021 Hassan
Foreign Patent Documents
3030001 Feb 1995 CN
304516482 Feb 2018 CN
000589643-0001 Oct 2006 EM
HJ2305860200 Dec 2011 JP
689585 Mar 1998 WO

Other References

Ingenioren ("The Engineer"), "Tabletter mod diabetes abner helt ny aera for Novo Nordisk," May 18, 2018, <https://ing.dk/artikel/tabletter-mod-diabetes-aabner-helt-ny-aera-nov- o-nordisk-212236>, visited on Mar. 3, 2019. cited by applicant .
Medwatch, "Novo Nordisk chases competitive edge with new version of GLP-1 tablet," Sep. 19, 2018, <https://medwatch.dk/secure/Top_picks_in_english/article10874729.ece&g- t;. cited by applicant .
U.S. Appl. No. 29/684,226, filed Mar. 19, 2019. (Unpublished) . cited by applicant.

Primary Examiner: Hanson; Charles D
Attorney, Agent or Firm: Saidman DesignLaw Group, LLC

Description



FIG. 1 is a top perspective view of a pill showing our new design;

FIG. 2 is a bottom perspective view thereof;

FIG. 3 is a front view thereof;

FIG. 4 is a rear view thereof;

FIG. 5 is a left side view thereof;

FIG. 6 is a right side view thereof;

FIG. 7 is a top view thereof;

FIG. 8 is a bottom view thereof;

FIG. 9 is a bottom perspective view of another embodiment thereof, the top perspective, front, rear, left side, right side, and top views being identical to FIG. 1 and FIGS. 3-7;

FIG. 10 is a bottom view thereof;

FIG. 11 is a bottom perspective view of another embodiment thereof, the top perspective, front, rear, left side, right side, and top views being identical to FIG. 1 and FIGS. 3-7; and,

FIG. 12 is a bottom view thereof.

* * * * *

References


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed